HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kremsner, P. G. Articles by Bienzle, U. Search for Related Content PubMed PubMed Citation Articles by Kremsner, P. G. Articles by Bienzle, U.

Curing of Chloroquine-Resistant Malaria with Clindamycin

A randomized comparative trial for treating adult patients with Plasmodium falciparum malaria was performed in Lambarene, Gabon. Forty-two patients received chloroquine (25 mg/kg for 48 hr) and 38 patients received clindamycin (5 mg/kg twice a day, for five days). Chloroquine treatment cured 15 patients (36%). Twenty patients (48%) showed recrudescent malaria by day 28 of follow-up (RI resistance) and seven patients (17%) showed persistent parasitemia after chloroquine treatment (RII/III resistance). In contrast, clindamycin treatment cured 37 of 38 patients (97%) and only one (3%) showed a recrudescence by day 28 (P < 0.001). Although the parasite clearance time was significantly longer after clindamycin treatment (median five days, range 3–6) than after chloroquine treatment (median four days, range 2–8) (P < 0.01), no differences were seen in the duration of symptoms after chemotherapy. In both treatment groups, no severe side effects occurred. Clindamycin can be used as a safe alternative to achieve radical cure in semi-immune adult patients with chloroquine-resistant P. falciparum malaria in Central Africa.

This article has been cited by other articles:

				J. Wiesner, D. Henschker, D. B. Hutchinson, E. Beck, and H. Jomaa In Vitro and In Vivo Synergy of Fosmidomycin, a Novel Antimalarial Drug, with Clindamycin Antimicrob. Agents Chemother., September 1, 2002; 46(9): 2889 - 2894. [Abstract] [Full Text] [PDF]

				B. Lell and P. G. Kremsner Clindamycin as an Antimalarial Drug: Review of Clinical Trials Antimicrob. Agents Chemother., August 1, 2002; 46(8): 2315 - 2320. [Full Text] [PDF]